Research · Sep 3, 2026
[CON] Concentra Group Holdings Thesis 2026: Occupational-Health + Workers-Compensation Compounder
Concentra Group Holdings Parent, Inc. (NYSE: CON), headquartered in Addison, Texas, is an Occupational-Health-Services-and-Workers-Compensation + emerging-multi-cycle-Spin-Off-2024-Select-Medical leader providing distinctive multi-cycle Occupational-Health-Services-Centers + emerging-Onsite-Workplace-Healthcare + emerging-Mobile-Onsite-Health + emerging-Workers-Compensation-Injury-Care + emerging-DOT-Department-of-Transportation-Compliance services to substantial multi-cycle US-Workers-Compensation-Insurer + multi-cycle-emerging-Employer-Workers-Compensation-Self-Insured + multi-cycle-emerging-DOT-Department-of-Transportation-Compliance + multi-cycle-emerging-Pre-Employment-Drug-Testing-and-Physical + multi-cycle-emerging-Veterans-Health-Administration-VHA-Partner customer base. The company has distinctive multi-cycle Concentra-Group-Holdings-and-Addison-TX-and-Occupational-Health-Services heritage: founded 1979 as OccuSystems-Occupational-Healthcare-Partnership; 1997-OccuSystems-merged-CRA-Concentra-Managed-Care; 2008 substantial Concentra-acquired-Welsh-Carson-Anderson-Stowe-private-equity; 2011 substantial Concentra-acquired-Humana ($790M from Welsh-Carson); 2015 substantial Concentra-Select-Medical-acquired-from-Humana ($1.06B); 2018 substantial Welsh-Carson-Anderson-Stowe-private-equity-acquired-minority; 2024 substantial Spin-Off-Select-Medical-Holdings (~$3.5B providing distinctive Concentra-NYSE-IPO 2024-July); 2024 Robert-A-Ortenzio-Executive-Chairman; 2024 Keith-Newton-CEO; multi-cycle-disciplined-bolt-on-M&A. FY2025 closes with selected various aggregate revenue ~$1.95-2.20B (~3-7% YoY-growth + emerging-multi-cycle-Occupational-Health-Services-and-Workers-Compensation-growth), adjusted EBITDA ~$385-455M (~19-22% margins reflecting Occupational-Health-Services-Highest-Margin economics), adjusted EPS ~$1.35-1.75, net debt ~$1.45-1.65B (~3.5-4.5x leverage post-2024-Spin-Off-Select-Medical), and ~127-132M shares post-2024-Spin-Off-Select-Medical under Executive Chairman Robert A. Ortenzio + President & CEO Keith Newton. The Occupational-Health-Services-Centers-and-Onsite-Workplace-Healthcare-and-Mobile-Onsite franchise deep-dive covers distinctive multi-cycle ~11,000+ employees + ~550+ Occupational-Health-Centers-and-Onsite-Workplace-Healthcare-and-Mobile-Onsite-Health across US (Addison-TX-HQ + Multi-Occupational-Health-Centers-44-States-and-DC + Multi-Onsite + Multi-Mobile-Onsite), Occupational-Health-Services-Centers ~85-90% revenue + Onsite-Workplace-Healthcare-and-Mobile-Onsite ~10-15% revenue, substantial multi-cycle US-Workers-Compensation-Insurer customer base, 2024-Spin-Off-Select-Medical-Holdings (~$3.5B Concentra-NYSE-IPO 2024-July) transformational-platform, emerging-multi-cycle US-Occupational-Health-Services structural-tailwinds, competing in Occupational-Health-Services space with US HealthWorks/UnitedHealth-Optum, AmeriHealth Caritas, HealthFitness/Trustmark, Premise Health, Marathon Health, Crossover Health, Eden Health, One Medical/Amazon, Walgreens VillageMD/Cigna-Evernorth, Walmart Health, Amazon Clinic, CVS Caremark/Oak Street, DaVita; Workers-Compensation-Insurance Hartford, Travelers, Liberty Mutual, Berkshire Hathaway, Zurich, AIG, Chubb, AmTrust/Stone Point; Workers-Compensation-Specialty-Pharmacy One Call Care, CorVel, Mitchell-Genex-Coventry/Stone Point; and private-equity-Welsh-Carson-Anderson-Stowe (largest Concentra Investor) + Apollo-Carlyle-Bain-KKR-Blackstone-CDR-Veritas-Genstar-American-Securities-Stone-Point-Lovell-Minnick-Hellman-Friedman-Silver-Lake-TPG-Reverence-Warburg-Pincus-Ares-Centerbridge-GTCR-Linden-Avista. The Robert-A-Ortenzio + Keith-Newton + 2024-Spin-Off-Select-Medical + multi-decade compounder thesis deep-dive covers Robert-A-Ortenzio-Executive-Chairman + Keith-Newton-CEO expertise + multi-cycle-Concentra-Group-Holdings-Capital-Management leadership-continuity, 1979-OccuSystems + 1997-CRA-Concentra-Managed-Care-merged + 2008-Welsh-Carson-private-equity-acquired + 2011-Humana-acquired + 2015-Select-Medical-acquired + 2018-Welsh-Carson-private-equity-acquired-minority + 2024-substantial-Spin-Off-Select-Medical-Holdings transformational-platform, emerging-2024-dividend-initiated (~$0.16/yr, ~0.5-1.0% yield) + emerging-multi-cycle-substantial-share-buyback (~$25-100M/yr) + multi-cycle-2024-Spin-Off-Select-Medical-debt-paydown-priority. Capital position is High-Yield (B1/B+ to Ba3/BB- ~3.5-4.5x leverage post-2024-Spin-Off-Select-Medical). At ~$20-26 per share, equity value ~$2.55-3.40B, EV ~$4.0-5.05B, providing ~12-18x EPS and ~9-13x EV/EBITDA.